Scheme 3 Reagents and conditions: i, NaOH, EtOH, 10 min; ii, Ac2O, cat.
DMAP, pyridine, 24 h, 82%; iii, NaOH, EtOH, 10 min; iv Ac2O, cat.
DMAP, pyridine, 24 h, 86%.
introduced a novel oxidising system, using quinudidine N-
oxide, which is capable of dihydroxylating certain allylic
amides with hydrogen-bonding control∑ and which uses cata-
lytic OsO4.
We wish to thank the EPSRC (K. B.) and Zeneca Pharmaceu-
ticals (Strategic Research Fund) for financial support.
Notes and references
Scheme 2 Reagents and conditions: i, MeOH (1.1 equiv.), BF3·OEt2 (0.5
equiv.), toluene, 220 °C–room temp., 1 h, 89%; ii, K2CO3 (0.5 equiv.),
MeOH–H2O (4+1), room temp., 1 h, 92%; iii, TBDMSCl (1.1 equiv.), Et3N
(2.2 equiv.), CH2Cl2, room temp., 24 h, 91%; iv, DBU (1.2 equiv.), CCl3CN
(1.3 equiv.), CH2Cl2, 220 °C–room temp., 98%; v, Ph2O, cat. K2CO3,
195 °C, 3 h, 64%; vi, NMO (1.5 equiv.), cat. OsO4, acetone–H2O (4+1),
room temp., 75%; vii, TMEDA (1.05 equiv.), OsO4 (1.05 equiv.), CH2Cl2,
278 °C–room temp., then MeOH–HCl, then Ac2O, 92%; viii, quinuclidine
(1.1 equiv.), OsO4 (1.05 equiv.), CH2Cl2, 278 °C–room temp., then
MeOH–HCl, then Ac2O, 90%; ix, quinuclidine N-oxide (2.0 equiv.), cat.
OsO4, CH2Cl2, room temp., 80%; x, Me3NO·2H2O (1.5 equiv.), cat. OsO4,
CH2Cl2, room temp., 87%.
‡ A similar strategy has been adopted previously for the synthesis of
allosamine. However, the reported route is troubled by both a low yielding
Overman rearrangement (30%) and oxidation with RuO4 (50%).
§ Crystal data for C18H20NO7Cl3 12: M = 468.70, orthorhombic, a =
12.862(7), b = 27.763(6), c = 6.007(4) Å3, T = 296 K, space group P2,2,2,
(no. 19), Z = 4, m(Cu-Ka) = 4.225 mm21, 2179 independent reflections
which were used in all calculations. The final wR(F2) was 0.1554 (all data).
R(F) was 0.0499 using 1703 reflections with I > 2s(I). The structure was
solved using direct methods and developed using difference Fourier
techniques, then refined by full matrix least-squares on F2. CCDC
182/1357.
¶ Selected data for 13: [a]D +69 (c 5.33, EtOH); dH(300 MHz; CDCl3) 5.83
(d, 1H, J 9.3), 5.51 (dd, 1H, J 3.0, 3.5), 4.97 (dd, 1H, J 3.0, 10.2), 4.68 (d,
1H, J 4.4), 4.48 (ddd, 1H, J 3.5, 4.4, 9.3), 4.30-4.15 (m, 3H), 3.42 (s, 3H),
2.16 (s, 3H), 2.09 (s, 3H), 1.99 (s, 3H) 1.97 (s, 3H); dC (75 MHz; CDCl3)
170.6, 170.4, 169.2, 169.0, 97.6, 68.3, 66.0, 63.0, 62.1, 55.7, 47.4, 23.0,
20.9, 20.6, 20.4. For 14: [a]D +72 (c 0.80, CHCl3); dH(300 MHz; CDCl3)
6.39 (d, 1H, J 9.6), 5.40 (m, 1H), 5.34 (dd, 1H, J 3.5, 4.5), 4.91 (d, 1H, J 1.1),
4.68 (d, 1H, J 11.6), 4.54 (d, 1H, J 11.6), 4.48 (dddd, 1H, J 9.6, 4.7, 1.1, 1.1),
4.27 (ddd, 1H, J 7.1, 6.2, 1.3), 4.12 (ABX, 2H, JAB 11.1, JAX 6.2 JBX 7.1),
2.18 (s, 3H), 2.07 (s, 3H), 2.03 (s, 3H) 1.99 (s, 3H); dC(75 MHz; CDCl3)
170.3, 169.4, 169.4, 168.9, 136.2, 128.5, 128.1, 128.0, 99.1, 69.8, 67.7,
66.5, 64.7, 61.7, 48.5, 23.4, 20.6, 20.5.
corresponding N-oxide (with sufficient water added to allow the
catalytic cycle to turn over). So, the use of quinuclidine N-oxide
(2 equiv.)8 and catalytic OsO4 (5 mol%) with approximately 4
equiv. of water, also gave an excellent level of syn stereo-
selectivity (step ix). This novel oxidising system gave better
stereoselectivity than that observed by using trimethylamine N-
oxide as a reoxidant (step x).9
The relative stereochemistry of the allosamine series of
compounds was proven by an X-ray crystal structure on the
benzylidine protected derivative 12 (Fig. 1).§
∑ Oxidation of 5 with quinuclidine N-oxide under the conditions described
in Scheme 2 gave a 1+1 mixture of stereoisomers. However, other allylic
amides do give syn selective results using this oxidant; details will be
reported in due course.
1 M. J. Crumpton, Nature, 1957, 180, 605; R. Heyworth and P. G. Walker,
Proc. Int. Congr. Biochem. 4th, 1958, 1, 7.
2 See, D. J. Kassab and B. Ganem, J. Am. Chem. Soc., 1999, 64, 1782 and
references therein.
3 T. J. Donohoe, K. Blades, P. R. Moore, J. J. G. Winter, M. Helliwell and
G. Stemp, J. Org. Chem., 1999, 64, 2980; T. J. Donohoe, P. R. Moore,
M. J. Waring and N. J. Newcombe, Tetrahedron Lett., 1997, 38, 5027;
for early studies in this area see: H. C. Kolb, M. S. VanNieuwenhze and
K. B. Sharpless, Chem. Rev., 1994, 94, 2483.
4 K. Takeda, E. Kaji, Y. Konda, N. Sato, H. Nakamura, N. Miya, A.
Morizane, Y. Yanagisawa, A. Akiyama, S. Zen and Y. Harigaya,
Tetrahedron Lett., 1992, 33, 7145.
5 T. Sugai, H. Okazaki, A. Kuboki and H. Ohta, Bull. Chem. Soc. Jpn.,
1997, 70, 2535.
6 T. Nishikawa, M. Asai, N. Ohyabu and M. Isobe, J. Org. Chem., 1998,
63, 188.
Fig. 1 X-Ray structure of 12.
As amino-sugars frequently occur in nature as their N-acetyl
derivatives, we removed the trichloroacetyl group and added an
acetyl functionality. This was accomplished readily in a two
stage, one pot process (Scheme 3).¶ Compound 14 prepared by
this route is known in the literature10 and displayed character-
istics identical to those previously reported (1H NMR, [a]D);
this correlation proves the stereochemistry of the talosamine
series described in Scheme 1.
7 T. J. Donohoe, K. Blades, M. Helliwell, M. J. Waring, and N. J.
Newcombe, Tetrahedron Lett., 1998, 39, 8755.
To conclude, we have prepared protected forms of two
naturally occurring and rare amino-sugars, talosamine and
allosamine: both compounds are available in high yield and
with excellent levels of stereoselectivity. These derivatives are
ideally configured for further elaboration into polysaccharides
and work is continuing in this direction. Moreover, we have
8 I. A. O’Neil, J. Y. Q. Lai and D. Wynn, Chem. Commun., 1999, 59.
9 G. Poli, Tetrahedron Lett., 1989, 30, 7385; T. J. Donohoe, R. Garg and
P. R. Moore, Tetrahedron Lett., 1996, 37, 3407; T. J. Donohoe, P. R.
Moore and R. L. Beddoes, J. Chem. Soc., Perkin Trans. 1, 1997, 43.
10 A. Banaszek and W. Karpiesiuk, Carbohydr. Res., 1994, 251, 233.
Communication 9/04991F
1734
Chem. Commun., 1999, 1733–1734